Reviewing Reata Pharmaceuticals Inc. (RETA)’s and Intec Pharma Ltd. (NASDAQ:NTEC)’s results

Since Reata Pharmaceuticals Inc. (NASDAQ:RETA) and Intec Pharma Ltd. (NASDAQ:NTEC) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation of both companies.

Valuation Earnings

In table 1 we can see Reata Pharmaceuticals Inc. and Intec Pharma Ltd.’s top-line revenue, earnings per share (EPS) and valuation.

Profitability

Table 2 represents Reata Pharmaceuticals Inc. (NASDAQ:RETA) and Intec Pharma Ltd. (NASDAQ:NTEC)’s return on equity, return on assets and net margins.

Insider Institutional Ownership

Reata Pharmaceuticals Inc. and Intec Pharma Ltd. has shares held by institutional investors as follows: 68.6% and 39.64%. Insiders held 4.1% of Reata Pharmaceuticals Inc. shares. Comparatively, 11.81% are Intec Pharma Ltd.’s share held by insiders.

Performance

In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance

... read more at: https://moveefy.com/2019/03/16/reviewing-reata-pharmaceuticals-inc-retas-and-intec-pharma-ltd-nasdaqntecs-results/

by